Propionic aci derivatives

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC M01AE
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector RX_PROPIONIX

Extra metadata

First used in FinnGen datafreeze DF4

Similar endpoints

Summary Statistics

Key figures

All Female Male
Number of individuals 153215 94385 58830
Unadjusted prevalence (%) 58.92 64.23 52.03
Mean age at first event (years) 41.28 39.55 44.06

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 0.88 [0.81, 0.95] 1.2e-3 8146
15 years 0.01 0.91 [0.84, 0.97] 5.2e-3 5011
5 years 0.00 0.93 [0.85, 1.02] 1.1e-1 1010
1 year 0.00 0.76 [0.62, 0.93] 6.7e-3 146

Correlations

Index endpoint: RX_PROPIONIX – Propionic aci derivatives
GWS hits:

Survival analyses between endpoints

Plot

before Propionic aci derivatives
after Propionic aci derivatives

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Propionic aci derivatives